Portage Biotech Inc. Files Form 6-K
Ticker: ATON · Form: 6-K · Filed: Aug 27, 2024 · CIK: 1095435
| Field | Detail |
|---|---|
| Company | Portage Biotech INC. (ATON) |
| Form Type | 6-K |
| Filed Date | Aug 27, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, regulatory-filing, foreign-private-issuer
Related Tickers: PRTG
TL;DR
Portage Biotech Inc. (PRTG) filed a 6-K, standard foreign issuer report, no major news.
AI Summary
Portage Biotech Inc. filed a Form 6-K on August 27, 2024, for the month of August 2024. The filing is a report of a foreign private issuer and is incorporated by reference into the company's registration statements. The company is incorporated in the British Virgin Islands and its fiscal year ends on March 31.
Why It Matters
This filing indicates ongoing reporting requirements for Portage Biotech Inc., a foreign private issuer, which is important for investors tracking the company's regulatory compliance and disclosures.
Risk Assessment
Risk Level: low — This filing is a routine report of a foreign private issuer and does not contain new material financial information or strategic changes.
Key Players & Entities
- Portage Biotech Inc. (company) — Filer of the Form 6-K
- 001-40086 (company) — SEC File Number for Portage Biotech Inc.
- 20240827 (date) — Filing date of the Form 6-K
- 20240630 (date) — Conformed period of report
FAQ
What type of filing is this Form 6-K?
This Form 6-K is a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934.
When was this Form 6-K filed?
This Form 6-K was filed on August 27, 2024.
What period does this report cover?
This report is for the month of August 2024, with a conformed period of report of June 30, 2024.
Where is Portage Biotech Inc. incorporated?
Portage Biotech Inc. is incorporated in the British Virgin Islands.
Does Portage Biotech Inc. file annual reports under Form 20-F or 40-F?
Portage Biotech Inc. files annual reports under Form 20-F.
Filing Stats: 316 words · 1 min read · ~1 pages · Grade level 10 · Accepted 2024-08-27 06:05:22
Filing Documents
- f6k_082624.htm (6-K) — 15KB
- exh_991.htm (EX-99.1) — 821KB
- exh_992.htm (EX-99.2) — 219KB
- aaplat.jpg (GRAPHIC) — 24KB
- ieplat.jpg (GRAPHIC) — 34KB
- agentact.jpg (GRAPHIC) — 42KB
- 0001171843-24-004936.txt ( ) — 5458KB
- ptgef-20240630.xsd (EX-101.SCH) — 85KB
- ptgef-20240630_cal.xml (EX-101.CAL) — 57KB
- ptgef-20240630_def.xml (EX-101.DEF) — 188KB
- ptgef-20240630_lab.xml (EX-101.LAB) — 323KB
- ptgef-20240630_pre.xml (EX-101.PRE) — 311KB
- f6k_082624_htm.xml (XML) — 877KB
Management's Discussion and Analysis for the three months ended June 30, 2024
Management's Discussion and Analysis for the three months ended June 30, 2024. 101.INS Inline XBRL Instance Document. 101.SCH Inline XBRL Taxonomy Extension Schema Document. 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF Inline XBRL Taxonomy Definition Linkbase Document 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: August 26, 2024 PORTAGE BIOTECH INC. By: /s/ Allan Shaw Allan Shaw Chief Financial Officer